| 000 | 01625 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515100706.0 | ||
| 264 | 0 | _c20080319 | |
| 008 | 200803s 0 0 eng d | ||
| 022 | _a1535-7163 | ||
| 024 | 7 |
_a10.1158/1535-7163.MCT-07-0133 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Zhijie | |
| 245 | 0 | 0 |
_aInactivation of glycogen synthase kinase-3beta contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells. _h[electronic resource] |
| 260 |
_bMolecular cancer therapeutics _cDec 2007 |
||
| 300 |
_a3113-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Intramural | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBrain-Derived Neurotrophic Factor _xphysiology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 |
_aEtoposide _xpharmacology |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aGlycogen Synthase Kinase 3 beta |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
| 650 | 0 | 4 |
_aNeuroblastoma _xdrug therapy |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 | _aRNA, Small Interfering |
| 650 | 0 | 4 |
_aReceptor, trkB _xphysiology |
| 700 | 1 | _aTan, Fei | |
| 700 | 1 | _aThiele, Carol J | |
| 773 | 0 |
_tMolecular cancer therapeutics _gvol. 6 _gno. 12 Pt 1 _gp. 3113-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1535-7163.MCT-07-0133 _zAvailable from publisher's website |
| 999 |
_c17602432 _d17602432 |
||